Effect of Bimekizumab on Patient-Reported Outcomes and Work Productivity in Patients With Psoriatic Arthritis: 1-Year Results From 2 Phase III Studies

Gladman DD, Mease PJ, Gossec L, Husni ME, Gottlieb AB, Ink B, Bajracharya R, Coarse J, Lyris N, Lambert J, Tillett W. Effect of Bimekizumab on Patient-Reported Outcomes and Work Productivity in Patients With Psoriatic Arthritis: 1-Year Results From 2 Phase III Studies. J Rheumatol. 2025;52(5):466-478. doi:10.3899/jrheum.2024-0923. | PMID: N/A

This study reports on the effect of bimekizumab on patient-reported outcomes including quality of life and work productivity over one year among patients with psoriatic arthritis from two phase III clinical trials.

Key Learning Points

• •
  Bimekizumab treatment significantly improved patient-reported outcomes related to pain, physical function, and quality of life at 1 year.
• •
  Improvements in work productivity and daily activities were sustained throughout the 1-year follow-up period.